Press & Statements

CSRXP: COVID-19 TREATMENTS AND VACCINES MUST BE ACCESSIBLE AND AFFORDABLE FOR ALL AMERICANS

Nov 9, 2020

Pfizer Releases Positive Preliminary Data on Vaccine, Must Commit to Read More

CSRXP: GILEAD’S PRICE-GOUGING AMERICAN PUBLIC ON COVID-19 TREATMENT TAXPAYERS PAID TO DEVELOP

Oct 30, 2020

Big Pharma Company Reaping Profit Margin Higher Than 90 Percent on Remdesivir Read More

CSRXP: PRESIDENTIAL CAMPAIGNS MUST BACK BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE

Oct 13, 2020

Surrogates for the 2020 Candidates Should Demonstrate Commitment To Lowering Read More

CSRXP: ASTRAZENECA LEADS BIG PHARMA IN BRAZEN ASSAULT ON CRITICAL 340B PROGRAM, MUST BE HELD ACCOUNTABLE

Oct 1, 2020

Brand Name Drug Company Shirks Requirement to Provide Affordable Medications Read More

CSRXP COMMENDS LAWMAKERS FOR REFOCUSING CRITICAL ATTENTION ON BIG PHARMA’S EGREGIOUS PRICE HIKES AND PRACTICES

Sep 30, 2020

House Committee on Oversight and Reform to Question Big Pharma Executives Read More

NEW STUDY: BIG PHARMA’S BIOLOGIC PATENT ABUSE WILL COST AMERICAN PATIENTS AN ADDITIONAL $25 BILLION WITHOUT REFORM

Sep 22, 2020

Report Finds Market-Based Solutions to Boost Biosimilar Competition and Hold Read More

CSRXP: PRESIDENT SHOULD FOCUS ON HOLDING BIG PHARMA ACCOUNTABLE TO LOWER RX PRICES, ABANDON REBATE RULE

Sep 13, 2020

Tweet Misstates Impact of Misguided Rebate Rule That Would Do Nothing to Lower Read More

CSRxP Commends Congressional Probe Of Big Pharma Giant’s Anti-Competitive Tactics and Egregious Pricing Practices

Sep 1, 2020

U.S. House Oversight Committee Subpoena of AbbVie Related to Pricing of Read More

BIG PHARMA DOUBLES DOWN ON SUMMER PRICE HIKES AS AMERICANS CONTINUE TO BATTLE PANDEMIC

Aug 27, 2020

Tracking Data Finds Drug Companies Increased Prices On at Least 67 Brand Name Read More

CSRXP: BIG PHARMA’S COUNTEROFFER TO WHITE HOUSE WOULD HURT AMERICAN SENIORS & DO NOTHING TO LOWER DRUG PRICES

Aug 26, 2020

White House Should Reject Pharma-Backed Policies That Would Hand Drug Read More

CSRXP LAUNCHES TELEVISION AND DIGITAL AD CAMPAIGN AGAINST REBATE RULE, AKA BIG PHARMA BAILOUT

Aug 4, 2020

Encourages Administration to Reject Measure That Would Increase Premiums on Read More

CSRXP: WHITE HOUSE MUST STAND UP TO BIG PHARMA AND HOLD INDUSTRY ACCOUNTABLE FOR PRICE HIKES

Jul 27, 2020

Administration Should Withdraw Big Pharma-Backed Policies Like the Rebate Read More